TipRanks
XTL Biopharmaceuticals Ltd. (IL:XTLB)
TASE:XTLB
Israel Market
XTLB
Xtl Bio
RESEARCH TOOLSreports

Xtl Bio (XTLB) Income Statement

0 Followers

Xtl Bio Income Statement

Last quarter (Q2 2025), Xtl Bio's total revenue was $258.50K, an increase of Infinity% from the same quarter last year. In Q2, Xtl Bio's net income was $-2.75M. See Xtl Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 451.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 3.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 1.69M$ 2.17M$ 765.00K$ 880.00K$ 1.03M
Depreciation and Amortization
$ 199.00K$ 199.00K$ 1.00K$ 1.00K$ 1.00K
EBITDA
$ -1.27M$ -930.00K$ -764.00K$ -879.00K$ -1.03M
Operating Income
$ -1.69M$ -2.17M$ -765.00K$ -880.00K$ -1.03M
Other Income/Expenses
$ 929.00K$ 1.01M$ -1.02M$ -468.00K$ 1.47M
Pretax Income
$ -759.00K$ -1.16M$ -1.78M$ -1.35M$ 435.00K
Net Income
$ -6.97M$ -1.03M$ -1.78K$ -1.35M$ 435.00K
Per Share Metrics
Basic EPS
$ >-0.01$ 0.00$ -0.01$ >-0.01$ <0.01
Diluted EPS
$ >-0.01$ 0.00$ -0.01$ >-0.01$ <0.01
Weighted Average Shares Outstanding
 896.17M 673.04M 544.91M 544.91M 615.55M
Weighted Average Shares Outstanding (Diluted)
 896.17M 704.16M 544.91M 544.91M 615.55M
Currency in USD

Xtl Bio Earnings and Revenue History